mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.09 |
mRNA |
BRD4132 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.09 |
mRNA |
BRD-K09344309 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.1 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.1 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.1 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.1 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.1 |
mRNA |
RAF265 |
CCLE |
pan-cancer |
AAC |
-0.078 |
0.1 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.1 |